Copie-Bergman, Christiane <br/><br/>
Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Nov 2009 
 - 5573-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2009.22.7058  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Biomarkers--blood<br/>Cyclophosphamide<br/>Dose-Response Relationship, Drug<br/>Doxorubicin<br/>Drug Administration Schedule<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Genes, myc<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Predictive Value of Tests<br/>Prednisone<br/>Probability<br/>Prognosis<br/>Proportional Hazards Models<br/>Proto-Oncogene Proteins c-bcl-2--analysis<br/>Risk Assessment<br/>Rituximab<br/>Severity of Illness Index<br/>Survival Analysis<br/>Treatment Outcome<br/>Vincristine